Raben Nina, Puertollano Rosa
Laboratory of Muscle Stem Cells and Gene Regulation, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland 20892; email:
Cell Biology and Physiology Center, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland 20892; email:
Annu Rev Cell Dev Biol. 2016 Oct 6;32:255-278. doi: 10.1146/annurev-cellbio-111315-125407. Epub 2016 Jun 1.
In recent years, our vision of lysosomes has drastically changed. Formerly considered to be mere degradative compartments, they are now recognized as key players in many cellular processes. The ability of lysosomes to respond to different stimuli revealed a complex and coordinated regulation of lysosomal gene expression. This review discusses the participation of the transcription factors TFEB and TFE3 in the regulation of lysosomal function and biogenesis, as well as the role of the lysosomal pathway in cellular adaptation to a variety of stress conditions, including nutrient deprivation, mitochondrial dysfunction, protein misfolding, and pathogen infection. We also describe how cancer cells make use of TFEB and TFE3 to promote their own survival and highlight the potential of these transcription factors as therapeutic targets for the treatment of neurological and lysosomal diseases.
近年来,我们对溶酶体的认识发生了巨大变化。溶酶体以前被认为仅仅是降解性细胞器,现在则被视为许多细胞过程中的关键参与者。溶酶体对不同刺激作出反应的能力揭示了溶酶体基因表达的复杂且协调的调控机制。本综述讨论了转录因子TFEB和TFE3在溶酶体功能和生物发生调控中的作用,以及溶酶体途径在细胞适应各种应激条件(包括营养剥夺、线粒体功能障碍、蛋白质错误折叠和病原体感染)中的作用。我们还描述了癌细胞如何利用TFEB和TFE3来促进自身存活,并强调了这些转录因子作为治疗神经疾病和溶酶体疾病靶点的潜力。